McBee Brannin sold 56,531 shares of CoreWeave, Inc. at $87.69 for −$4.96M on Sep 30, 2026

Sell
Form 4 code S. Open-market or private sale of a non-derivative or derivative security.
Chief Development Officer
Chief Development Officer
Filed Oct 2, 2026

Facts from the filing

Form 4 · Non-derivative, table I
Disclosed value
−$4,957,203.39Shares × reported price
Shares traded
56,531Class A Common Stock
Price per share
$87.69Reported price. Read footnotes for ranges.
% of reported position traded
12.6%This security and ownership context
Holdings after
392,279Direct
Trade date
Sep 30, 2026Sell
Filed
Oct 2, 2026, 8:19 PM ET3-day reporting delay
Accession
0001769628-26-000443Code S · Transaction 236130
How reported position traded is calculated

Shares sold ÷ (holdings after + shares sold). Estimated position before: 448,810 shares.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Other trades in this filing

Trade dateActivitySharesPriceValueDetails
Sep 30, 2026Option exercise109,380——Trade 236128
Sep 30, 2026Option exercise11,739——Trade 236129
Sep 30, 2026Option exercise109,380——Trade 236131
Sep 30, 2026Option exercise11,739——Trade 236132
5 transaction rows in this filing. Joint filers share the same rows.

CRWV price since this filing

Daily closing prices, with the filing date and available return windows. Return methodology
CRWV · Daily closing priceDaily price data is pending. The chart appears when valid daily closes are available.
Filing dateReturn windows appear as prices become available.
Pre-filing1mo ago −5.3%1w ago −3%1d ago −4.1%
Returns since7d −8.4%30d −39%90d180d1y

Footnotes in full

F1: Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock upon settlement. F2: The reported transaction represents shares of Class A Common Stock of the Issuer sold to satisfy the reporting person's tax withholding obligations, which were incurred in connection with the vesting and settlement of restricted stock units. F3: The reported securities are directly held by the Canis Major SM Trust (the "Canis Trust"), an irrevocable trust with a third-party trustee, of which the reporting person's minor child is beneficiary. The reporting person has the power to remove and replace the Canis Trust's trustee. F4: The reported securities are directly held of record by the reporting person's child. F5: The award vested or vests as to 1/16 of the total award on the last day of March, June, September, and December, subject to the reporting person's continued service to the Issuer on each vesting date. The first tranche time-vested on March 31, 2025, and such vested shares were subsequently settled on May 31, 2025, pursuant to a deferral approved by the compensation committee of the Issuer's board of directors. F6: These restricted stock units do not expire; they either vest or are cancelled prior to the vesting date. F7: The award vested or vests as to 1/16 of the total award quarterly on the last day of June, September, December, and March, subject to the reporting person's continued service to the Issuer on each vesting date, with the first tranche vesting on June 30, 2025.